← Leaderboards
John Eldridge
Auro Vaccines Llc
$7,417,867
Attributed
$7,417,867
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $4.1M · FY2021–25$5M$3.8M$2.5M$1.3M$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$7,417,867 · 1
By mechanism
N01$7,417,867 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Vaccine Development”
- Bambra Strokes · Ppd Development Lp$526,656,217
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$143,577,666
- Kimberly Smith · Ppd Development Lp$115,671,664
- Yunda Huang · Fred Hutchinson Cancer Center$74,296,334
- Ted Ross · University Of Georgia$71,962,304
- Tony Moody · Duke University$68,143,568
Research focus
Vaccine DevelopmentContractsCyclic GmpVaccinesEbola VirusFilovirusFreeze DryingVaccine CandidateLassa FeverAdvanced DevelopmentMarburgvirusPathogenPreparationResearch Clinical TestingVaccine FormulationManufactureInvestigational New Drug ApplicationEbola VaccinesVirus
Grant awards (5)
Advanced Development of Vaccines for Filoviruses$61,916
N01 · FY2025 · AI · contact PI
Advanced Development of Vaccines for Filoviruses$1,033,940
N01 · FY2024 · AI · contact PI
Advanced Development of Vaccines for Filoviruses$4,095,421
N01 · FY2023 · AI · contact PI
Advanced Development of Vaccines for Filoviruses$1,239,978
N01 · FY2022 · AI · contact PI
Advanced Development of Vaccines for Filoviruses$986,612
N01 · FY2021 · AI · contact PI